CPhI N. America's keynote speaker explains what bipartisan bickering means for pharma
Why the industry is forming bonds with CBD
The commercialization of a new drug follows a rigid path and applying for FDA approval can be a minefield of challenges. Here are expert tips for nailing your application.
In pharma plants, age definitely matters.